Society Logo
ME/CFS Australia Ltd
Please click here to donate ME/CFS South Australia Inc
 
 
Facebook
 
ME/CFS SOUTH AUSTRALIA INC

Registered Charity 3104

Email:
sacfs@sacfs.asn.au

Mailing address:

PO Box 322,
Modbury North,
South Australia 5092

Phone:
1300 128 339

Office Hours:
Monday - Friday,
10am - 4pm
(phone)

ME/CFS South Australia Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.

Disclaimer

ME/CFS South Australia Inc aims to keep members informed of various research projects, diets, medications, therapies, news items, etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.

Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.

Become a Member
DOCX Application Form (Word, 198 KB)
Why become a member?

Sleep symptoms impair Fibromyalgia patients' quality of life

Thursday 25 October 2012

 

From medwireNews:

 

PillowSleep symptoms impair fibromyalgia patients’ QoL

By Lynda Williams, Senior medwireNews Reporter
22 October 2012
BMC MusculoskeletDisord 2012; 13: 199

medwireNews: A study of fibromyalgia patients highlights the impact of sleep symptoms on health-related quality of life (HRQoL) in this population.

Just 11.2% of 2196 fibromyalgia patients identified using the 2009 National Health and Wellness Survey reported no difficulty with falling asleep, staying asleep or early wakening, while 25.7% reported one and 63.1% two or three symptoms.

This pattern of symptoms differed significantly from that of 2194 age-, gender-, ethnicity- and comorbidity-matched controls, 40.7% of whom had no sleep symptoms, 29.0% had one symptom, and 30.3% had two or more.

Of concern, fibromyalgia patients with two or three sleep symptoms were significantly more likely than those with no or one symptoms to report both severe pain (43.26 vs 19.08 and 30.77%), and daily pain (70.88 vs 49.21 and 59.67%).

Difficulty sleeping also significantly correlated with fibromyalgia patient scores on the physical and mental domains of the Medical Outcomes Study Short Form-12 questionnaire version 2 (SF-12v2), with one or two/three symptoms associated with clinically relevant deficits in HRQoL.

Fibromyalgia patients had significantly poorer SF-12v2 scores than controls. Furthermore, the relationship between the number of sleep difficulties and the impact on HRQoL differed between patients and controls, "suggesting a uniqueness of the burden of sleep difficulties within the [fibromyalgia] population," say Marco DiBonaventura (Kantar Health, New York, USA) and co-authors.

They explain: "In most cases, the decrement between no sleep difficulty symptoms and one sleep difficulty symptom was larger among those patients with [fibromyalgia]; conversely, the quality of life decrement between one and two or more sleep difficulty symptoms was larger among matched controls."

Writing in BMC Musculoskeletal Disorders, the team concludes that "the improved management of these sleep difficulty symptoms among patients with FM may lead to clinically-relevant improvements in HRQoL."

While improving pain relief may reduce sleep symptoms, DiBonaventura et al note that HRQoL symptoms were influenced by sleep symptoms even after adjusting for pain management, indicating that "the management of sleep difficulties likely extends beyond the mere alleviation of pain."

medwireNews (www.medwire-news.md) is an independent clinical news service provided by Springer Healthcare Limited. © Springer Healthcare Ltd; 2012

Free full text [PDF]

 

The above originally appeared here.

 


Arrow right

More Fibromyalgia News

 


 

blog comments powered by Disqus
Previous Previous Page